Search filters

List of works by Emanuel Raschi

Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis

scientific article

Advancements in drug development for diarrhea-predominant irritable bowel syndrome.

scientific article published on 16 February 2018

Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems

scientific article published on 26 March 2018

Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies.

scientific article

Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications

scientific article published on 25 August 2016

Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.

scientific article published on 18 October 2017

Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system

scientific article

Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy

scientific article published on 27 October 2009

Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System

scientific article

Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database.

scientific article

Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy

scientific article

Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications

scientific article published in February 2013

Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database

scientific article

Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review

scientific article published on 23 January 2020

Association between the use of proton pump inhibitors and cardiovascular events: A note of caution

scientific article published on 01 February 2017

Authors' Reply to Alain Braillon's Comment on "The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project"

scientific article published on 01 April 2016

Authors' reply to Tufan and colleagues and Boucaud-Maitre

scientific article published in the British Medical Journal

Balancing the Need for Personalization of QT Correction and Generalization of Study Results: Going Beyond Thorough QT Studies

scientific article

Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?

scientific article published on 25 August 2020

Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

scientific article

Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology ⬇️

scientific article published on December 13, 2011

Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database

scientific article published in April 2012

Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice

scientific article

Comment on: "Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus"

scientific article published on 01 April 2015

Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews

scientific article published on 01 December 2019

Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment

scientific article published on 05 November 2020

Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.

scientific article published on 19 February 2016

Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance

scientific article published on 26 August 2020

Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk

scientific article published in July 2015

Drug-Induced Arrhythmia: Bridging the Gap Between Pathophysiological Knowledge and Clinical Practice

scientific article

Drug-induced Kounis syndrome: A matter of pharmacovigilance

scientific article published on 24 July 2018

Drug-induced liver injury: Towards early prediction and risk stratification

scientific article

Drug-induced renal damage in preterm neonates: state of the art and methods for early detection

scientific article

Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development

scientific article

Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?

scientific article published on 12 June 2019

Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS).

scientific article

ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations

scientific article

ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations-authors' reply

article

Emerging therapeutic uses of direct-acting oral anticoagulants: An evidence-based perspective

scientific article

Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project

scientific article published on 26 December 2016

Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon?

scientific article published on 07 August 2017

Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period

scientific article

Generic atypical antipsychotic drugs in Belgium: their influence and implications

scientific article published in November 2013

Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis

scientific article published on 14 February 2018

Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis

scholarly article by Julie Mouchet et al published June 2018 in Pharmacological Research

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase

scientific article published on 04 January 2021

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

scientific article published on 28 July 2020

Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis

scientific article published on 03 August 2020

Liver injury with direct-acting anticoagulants: has the fog cleared?

scientific article published in December 2017

Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System

scientific article published on 19 September 2018

Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system

scientific article

Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome

scientific article published on 03 January 2014

Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology

scientific article

Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System

scientific article published on 14 September 2018

Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug-drug interactions through the FDA adverse event reporting system

scientific article published on 15 June 2019

No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase

scientific article published on 16 February 2018

Observational research on sodium glucose co-transporter-2 inhibitors: A real breakthrough?

scientific article published on 14 August 2018

Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping

scientific article published on 9 June 2017

Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit

scientific article

Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation.

scientific article published on 5 March 2014

Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors

scientific article published on 04 October 2019

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems

scientific article published on 01 March 2018

Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective

scientific article

Potential to enhance the prescribing of generic drugs in patients with mental health problems in austria; implications for the future

scientific article published on January 2012

Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study

scientific article published on 07 May 2020

Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe

scientific article

QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus

scientific article published in November 2011

Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction

scientific article published on 19 March 2020

Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study

scientific article published on 12 November 2019

Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies

scientific article

Role of drugs and devices in patients at risk of sudden cardiac death.

scientific article published on October 2010

SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?

scientific article published on 03 November 2020

Safety Meta-Analysis: A Call for Appropriate Use of Disproportionality Measures From Spontaneous Reporting Systems

scientific article published on 01 May 2016

Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System

scientific article published on 06 August 2019

Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis

scientific article published on 07 January 2021

Serious adverse events with tocilizumab: pharmacovigilance as an aid to prioritize monitoring in COVID-19

scientific article published on 08 July 2020

Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis

scientific article published on 08 September 2020

Signal of potentially protective drug-drug interactions from spontaneous reporting systems: proceed with caution

scientific article published on 06 November 2019

Stroke, Migraine and Triptans: From Bedside to Bench

scientific article published on 6 April 2016

Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies.

scientific article published on 14 August 2015

Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy

scientific article

Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling

scientific article published on February 2011

The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.

scientific article

The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database.

scientific article published on 19 October 2011

The beta3-adrenoceptor as a therapeutic target: current perspectives

scientific article published on 24 January 2009

The hERG K+ channel: target and antitarget strategies in drug development

scientific article

The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practice

scientific article published on 13 November 2020

Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe

scientific article (publication date: 2013)

Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System

scientific article published on 01 April 2019

Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden

scientific article published on September 2012

Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey

scientific article

hERG-related drug toxicity and models for predicting hERG liability and QT prolongation

scientific article

Paulina is supported by:

About Paulina

Help